Synopsis
Bursitis is a swelling or inflammation of the bursa – a sac filled with a lubricating fluid and located between the tissues such as bone, skin, tendons and muscles. Lubricating fluid helps in reducing the friction, rubbing and irritation upon movement of a joint. Bursitis affects mainly elbow, hip, shoulder, knee and Achilles tendon. The most common symptoms of bursitis are pain, swelling and stiffness in affected area. Sudden or severe pain may gradually build up, if there is a presence of calcium deposits. Bursitis is commonly caused by the repetitive trauma of injuries on the affected area. Improper posture at home, work and poor stretching before exercise also lead to bursitis. A poorly or an abnormal placed bone or joint can put extra stress on a bursa sac, causing bursitis. Infection from other conditions such as thyroid disorder gout, or unusual medication reactions also increase a person’s risk for bursitis. Sometimes an infection can sometimes lead to inflammation of a bursa. In adults bursitis is very common especially those over 40 years of age. There are number of ways for bursitis treatment like resting the injured area, icing the area, avoiding activities that aggravate the problem, taking over the counter anti-inflammatory medicines and many more. Surgery may be an option when bursitis does not respond to the other treatment options but it is rarely needed.
The global Bursitis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bursitis Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores, are propelling Bursitis Treatment market. Corticosteroids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibiotic segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bursitis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bursitis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bursitis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bursitis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bursitis Treatment covered in this report include Teva Pharmaceutical, Crecent Therapeutics, Arinna Lifesciences Private, Sun Pharmaceutical Industries, Bioanalytical Systems, Perrigo Company and Arbor Pharmaceuticals, etc.
The global Bursitis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva Pharmaceutical
Crecent Therapeutics
Arinna Lifesciences Private
Sun Pharmaceutical Industries
Bioanalytical Systems
Perrigo Company
Arbor Pharmaceuticals
Global Bursitis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bursitis Treatment market, Segment by Type:
Corticosteroids
Antibiotic
Analgesics
Others
Global Bursitis Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bursitis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Bursitis Treatment
1.1 Bursitis Treatment Market Overview
1.1.1 Bursitis Treatment Product Scope
1.1.2 Bursitis Treatment Market Status and Outlook
1.2 Global Bursitis Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bursitis Treatment Market Size by Region (2018-2029)
1.4 Global Bursitis Treatment Historic Market Size by Region (2018-2023)
1.5 Global Bursitis Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bursitis Treatment Market Size (2018-2029)
1.6.1 North America Bursitis Treatment Market Size (2018-2029)
1.6.2 Europe Bursitis Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Bursitis Treatment Market Size (2018-2029)
1.6.4 Latin America Bursitis Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Bursitis Treatment Market Size (2018-2029)
2 Bursitis Treatment Market by Type
2.1 Introduction
2.1.1 Corticosteroids
2.1.2 Antibiotic
2.1.3 Analgesics
2.1.4 Others
2.2 Global Bursitis Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bursitis Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Bursitis Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bursitis Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bursitis Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bursitis Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bursitis Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bursitis Treatment Revenue Breakdown by Type (2018-2029)
3 Bursitis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.1.4 Drug Stores
3.2 Global Bursitis Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bursitis Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Bursitis Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bursitis Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bursitis Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bursitis Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bursitis Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bursitis Treatment Revenue Breakdown by Application (2018-2029)
4 Bursitis Treatment Competition Analysis by Players
4.1 Global Bursitis Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bursitis Treatment as of 2022)
4.3 Date of Key Players Enter into Bursitis Treatment Market
4.4 Global Top Players Bursitis Treatment Headquarters and Area Served
4.5 Key Players Bursitis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Bursitis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Teva Pharmaceutical
5.1.1 Teva Pharmaceutical Profile
5.1.2 Teva Pharmaceutical Main Business
5.1.3 Teva Pharmaceutical Bursitis Treatment Products, Services and Solutions
5.1.4 Teva Pharmaceutical Bursitis Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Teva Pharmaceutical Recent Developments
5.2 Crecent Therapeutics
5.2.1 Crecent Therapeutics Profile
5.2.2 Crecent Therapeutics Main Business
5.2.3 Crecent Therapeutics Bursitis Treatment Products, Services and Solutions
5.2.4 Crecent Therapeutics Bursitis Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Crecent Therapeutics Recent Developments
5.3 Arinna Lifesciences Private
5.3.1 Arinna Lifesciences Private Profile
5.3.2 Arinna Lifesciences Private Main Business
5.3.3 Arinna Lifesciences Private Bursitis Treatment Products, Services and Solutions
5.3.4 Arinna Lifesciences Private Bursitis Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Sun Pharmaceutical Industries Recent Developments
5.4 Sun Pharmaceutical Industries
5.4.1 Sun Pharmaceutical Industries Profile
5.4.2 Sun Pharmaceutical Industries Main Business
5.4.3 Sun Pharmaceutical Industries Bursitis Treatment Products, Services and Solutions
5.4.4 Sun Pharmaceutical Industries Bursitis Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Sun Pharmaceutical Industries Recent Developments
5.5 Bioanalytical Systems
5.5.1 Bioanalytical Systems Profile
5.5.2 Bioanalytical Systems Main Business
5.5.3 Bioanalytical Systems Bursitis Treatment Products, Services and Solutions
5.5.4 Bioanalytical Systems Bursitis Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Bioanalytical Systems Recent Developments
5.6 Perrigo Company
5.6.1 Perrigo Company Profile
5.6.2 Perrigo Company Main Business
5.6.3 Perrigo Company Bursitis Treatment Products, Services and Solutions
5.6.4 Perrigo Company Bursitis Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Perrigo Company Recent Developments
5.7 Arbor Pharmaceuticals
5.7.1 Arbor Pharmaceuticals Profile
5.7.2 Arbor Pharmaceuticals Main Business
5.7.3 Arbor Pharmaceuticals Bursitis Treatment Products, Services and Solutions
5.7.4 Arbor Pharmaceuticals Bursitis Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Arbor Pharmaceuticals Recent Developments
6 North America
6.1 North America Bursitis Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bursitis Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bursitis Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bursitis Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bursitis Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bursitis Treatment Market Dynamics
11.1 Bursitis Treatment Industry Trends
11.2 Bursitis Treatment Market Drivers
11.3 Bursitis Treatment Market Challenges
11.4 Bursitis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List